Dean, Isaac http://orcid.org/0000-0002-4750-5335
Lee, Colin Y. C. http://orcid.org/0000-0001-8380-4917
Tuong, Zewen K. http://orcid.org/0000-0002-6735-6808
Li, Zhi http://orcid.org/0000-0002-0583-1116
Tibbitt, Christopher A.
Willis, Claire
Gaspal, Fabrina
Kennedy, Bethany C. http://orcid.org/0000-0001-9529-7545
Matei-Rascu, Veronika
Fiancette, Rémi http://orcid.org/0000-0003-1531-9770
Nordenvall, Caroline
Lindforss, Ulrik
Baker, Syed Murtuza http://orcid.org/0000-0002-6633-333X
Stockmann, Christian
Sexl, Veronika
Hammond, Scott A. http://orcid.org/0000-0001-5800-4328
Dovedi, Simon J.
Mjösberg, Jenny http://orcid.org/0000-0002-1119-0976
Hepworth, Matthew R. http://orcid.org/0000-0002-9613-7858
Carlesso, Gianluca
Clatworthy, Menna R. http://orcid.org/0000-0002-3340-9828
Withers, David R. http://orcid.org/0000-0003-3757-7594
Funding for this research was provided by:
Cancer Research UK (C54019/A27535)
Cancer Research Institute (CRI3128)
Worldwide Cancer Research (21-0073)
Wellcome Trust (110199/Z/15/Z)
Article History
Received: 20 July 2023
Accepted: 2 January 2024
First Online: 24 January 2024
Competing interests
: The authors declare the following competing interests: G.C., S.A.H., S.J.D. are full-time employees of AstraZeneca and own or have owned AstraZeneca stock. The remaining author declare no competing interests.